These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23928409)

  • 1. MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation.
    Verhoeven CJ; Farid WR; de Ruiter PE; Hansen BE; Roest HP; de Jonge J; Kwekkeboom J; Metselaar HJ; Tilanus HW; Kazemier G; van der Laan LJ
    J Hepatol; 2013 Dec; 59(6):1231-8. PubMed ID: 23928409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes and consequences of ischemic-type biliary lesions after liver transplantation.
    Buis CI; Hoekstra H; Verdonk RC; Porte RJ
    J Hepatobiliary Pancreat Surg; 2006; 13(6):517-24. PubMed ID: 17139425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation.
    Heidenhain C; Pratschke J; Puhl G; Neumann U; Pascher A; Veltzke-Schlieker W; Neuhaus P
    Transpl Int; 2010 Jan; 23(1):14-22. PubMed ID: 19691661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application value of diffusion-weighted imaging in ischemic-type biliary lesions after liver transplantation].
    Liu JJ; Wang J; Shan H; He BJ; Xu CM; Jiang ZB; Li MA; Shao S; Zhou ZH
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):591-4. PubMed ID: 21600127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function.
    Verhoeven CJ; Farid WR; Roest HP; Ramakrishnaiah V; de Ruiter PE; de Jonge J; Kwekkeboom J; Metselaar HJ; Tilanus HW; Kazemier G; Ijzermans JN; van der Laan LJ
    Liver Int; 2016 Jun; 36(6):883-92. PubMed ID: 26344705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in the bile of patients with biliary strictures after liver transplantation.
    Lankisch TO; Voigtländer T; Manns MP; Holzmann A; Dangwal S; Thum T
    Liver Transpl; 2014 Jun; 20(6):673-8. PubMed ID: 24648209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers.
    Matton APM; Selten JW; Roest HP; de Jonge J; IJzermans JNM; de Meijer VE; Porte RJ; van der Laan LJW
    Clin Transplant; 2020 Mar; 34(3):e13790. PubMed ID: 31984571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic type biliary lesions in histidine-tryptophan-ketoglutarate (HTK) preserved liver grafts.
    Moench C; Otto G
    Int J Artif Organs; 2006 Mar; 29(3):329-34. PubMed ID: 16685677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation.
    Selten JW; Verhoeven CJ; Heedfeld V; Roest HP; de Jonge J; Pirenne J; van Pelt J; Ijzermans JNM; Monbaliu D; van der Laan LJW
    Liver Transpl; 2017 Jul; 23(7):946-956. PubMed ID: 28388830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.
    Farid WR; Pan Q; van der Meer AJ; de Ruiter PE; Ramakrishnaiah V; de Jonge J; Kwekkeboom J; Janssen HL; Metselaar HJ; Tilanus HW; Kazemier G; van der Laan LJ
    Liver Transpl; 2012 Mar; 18(3):290-7. PubMed ID: 21932376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete bile duct sequestration after liver transplantation, caused by ischemic-type biliary lesions.
    Abou-Rebyeh H; Veltzke-Schlieker W; Radke C; Steinmüller T; Wiedenmann B; Hintze RE
    Endoscopy; 2003 Jul; 35(7):616-20. PubMed ID: 12822100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation.
    Canelo R; Hakim NS; Ringe B
    Int Surg; 2003; 88(3):145-51. PubMed ID: 14584769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiologic factors and incidence of ischemic type biliary lesions (ITBL) after liver transplantation].
    Langrehr JM; Schneller A; Neuhaus R; Vogl T; Hintze R; Neuhaus P
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1560-2. PubMed ID: 9931943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures.
    op den Dries S; Westerkamp AC; Karimian N; Gouw AS; Bruinsma BG; Markmann JF; Lisman T; Yeh H; Uygun K; Martins PN; Porte RJ
    J Hepatol; 2014 Jun; 60(6):1172-9. PubMed ID: 24560661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary complications in liver transplantation: Impact of anastomotic technique and ischemic time on short- and long-term outcome.
    Kienlein S; Schoening W; Andert A; Kroy D; Neumann UP; Schmeding M
    World J Transplant; 2015 Dec; 5(4):300-9. PubMed ID: 26722658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver retransplantation for ischemic-type biliary lesions after orthotopic liver transplantation: a clinical report of 66 cases.
    Zhu ZJ; Rao W; Sun JS; Cai JZ; Deng YL; Zheng H; Zhang YM; Jiang WT; Zhang JJ; Gao W; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):471-5. PubMed ID: 18842491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience.
    Gulsen MT; Girotra M; Cengiz-Seval G; Price J; Singh VK; Segev DL; Cameron AM; Gurakar A
    Ann Transplant; 2013 Feb; 18():69-75. PubMed ID: 23792504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the histological appearance of the portal vein and development of ischemic-type biliary lesions after liver transplantation.
    Farid WR; de Jonge J; Zondervan PE; Demirkiran A; Metselaar HJ; Tilanus HW; de Bruin RW; van der Laan LJ; Kazemier G
    Liver Transpl; 2013 Oct; 19(10):1088-98. PubMed ID: 23843296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.